Studies
Report 19 - Bill C-64, An Act respecting pharmacare
Presented to the House: Tuesday, May 28, 2024
Report 15 - Bill C-284, An Act to establish a national strategy for eye care
Presented to the House: Wednesday, June 21, 2023
Report 14 - Bill C-293, An Act respecting pandemic prevention and preparedness
Presented to the House: Friday, October 27, 2023
Report 13 - Bill C-252, An Act to amend the Food and Drugs Act (prohibition of food and beverage marketing directed at children)
Presented to the House: Wednesday, April 26, 2023
Report 11 - Bill S-203, An Act respecting a federal framework on autism spectrum disorder
Presented to the House: Wednesday, March 22, 2023
Report 9 - Bill C-224, An Act to establish a national framework for the prevention and treatment of cancers linked to firefighting
Presented to the House: Wednesday, December 14, 2022
Report 8 - Bill C-252, An Act to amend the Food and Drugs Act (prohibition of food and beverage marketing directed at children)
Concurred in by the House: Wednesday, December 7, 2022
Report 7 - Bill C-224, An Act to establish a national framework for the prevention and treatment of cancers linked to firefighting
Concurred in by the House: Wednesday, December 7, 2022
Report 5 - Bill C-31, An Act respecting cost of living relief measures related to dental care and rental housing
Presented to the House: Tuesday, October 25, 2022
Report 12 - Main Estimates 2023-24: Votes 1 and 5 under Canadian Food Inspection Agency, Votes 1 and 5 under Canadian Institutes of Health Research, Votes 1, 5 and 10 under Department of Health, Vote 1 under Patented Medicine Prices Review Board and Votes 1, 5 and 10 under Public Health Agency of Canada
Presented to the House: Wednesday, April 26, 2023
Report 6 - Supplementary Estimates (B), 2022-23: Vote 1b under Canadian Food Inspection Agency, Votes 1b and 5b under Canadian Institutes of Health Research, Votes 1b and 10b under Department of Health, Votes 1b, 5b and 10b under Public Health Agency of Canada
Presented to the House: Monday, December 5, 2022
Report 2 - Main Estimates 2022-23: Votes 1 and 5 under Canadian Food Inspection Agency, Votes 1 and 5 under Canadian Institutes of Health Research, Votes 1, 5 and 10 under Department of Health, Vote 1 under Patented Medicine Prices Review Board and Votes 1, 5 and 10 under Public Health Agency of Canada
Presented to the House: Monday, March 28, 2022
Report 1 - Supplementary Estimates (C), 2021-22: Vote 1c under Canadian Food Inspection Agency, Votes 1c and 5c under Canadian Institutes of Health Research, Votes 1c and 10c under Department of Health and Votes 1c and 10c under Public Health Agency of Canada
Presented to the House: Monday, March 28, 2022
Report 20 - Breast Cancer Screening Guidelines
Presented to the House: Wednesday, June 19, 2024
Report 18 - Fostering Healthy Childhoods: A Foundation for Resilient Generations
Presented to the House: Monday, May 6, 2024
Report 17 - The Patented Medicine Prices Review Board: Ensuring the Effectiveness of the Reform Process
Presented to the House: Monday, May 6, 2024
Government Response
Presented to the House: Monday, September 16, 2024
Report 16 - Strengthening the Oversight of Breast Implants
Presented to the House: Thursday, November 30, 2023
Government Response
Presented to the House: Monday, April 8, 2024
Report 10 - Addressing Canada’s Health Workforce Crisis
Presented to the House: Monday, March 6, 2023
Government Response
Presented to the House: Monday, September 18, 2023
Report 4 - Over-the-Counter Paediatric Medication
Presented to the House: Wednesday, October 19, 2022
Report 3 - Full Participation of Taiwan in the World Health Assembly (WHA) and the World Health Organization (WHO)
Concurred in by the House: Wednesday, October 5, 2022